Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Naproxcinod

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024
    Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024

    24 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/24/2887770/0/en/Nicox-2024-Ordinary-Shareholder-Meeting-to-be-held-on-June-28th-2024.html

    GLOBENEWSWIRE
    24 May 2024
    Share Share
    Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
    Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting

    09 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/09/2860211/0/en/Nicox-2024-Ordinary-and-Extraordinary-Shareholder-Meeting.html

    GLOBENEWSWIRE
    09 Apr 2024
    Share Share
    Number of voting rights as of March 31, 2024
    Number of voting rights as of March 31, 2024

    02 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/02/2856272/0/en/Number-of-voting-rights-as-of-March-31-2024.html

    GLOBENEWSWIRE
    02 Apr 2024
    Share Share
    Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma
    Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma

    20 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/20/2849092/0/en/Results-from-Mont-Blanc-Phase-3-Trial-of-Nicox-s-NCX-470-in-Glaucoma-Published-in-the-American-Journal-of-Ophthalmology.html

    GLOBENEWSWIRE
    20 Mar 2024
    Share Share
    Number of votings rights as of January 31 2024
    Number of votings rights as of January 31 2024

    01 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/01/2822282/0/en/Number-of-votings-rights-as-of-January-31-2024.html

    GLOBENEWSWIRE
    01 Feb 2024
    Share Share
    Number of voting rights as of November 30, 2023
    Number of voting rights as of November 30, 2023

    01 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/01/2789431/0/en/Number-of-voting-rights-as-of-November-30-2023.html

    GLOBENEWSWIRE
    01 Dec 2023
    Share Share